Antiviral Therapy must be Offered to all Hepatitis C Patients, as Antiretrovirals to all HIV-Positive Individuals
Antiviral Therapy must be Offered to all Hepatitis C Patients, as Antiretrovirals to all HIV-Positive Individuals
Pablo Barreiro
Department of Infectious Diseases, Hospital Carlos III-La Paz University Hospital. Madrid, Spain
*Correspondence: Pablo Barreiro, Email not available
Abstract
Updated guidelines on hepatitis C from the AASLD/IDSA were released on July 2015 (www.hcvguidelines.org). The panel now strongly recommends oral antiviral treatment for all persons with chronic hepatitis C. It reflects the appreciation of both hepatic and extrahepatic benefits in individuals cured from HCV infection, even in those with minimal or null hepatic fibrosis (Metavir F0F1). The statement is a critical decision, with strong implications for medical services and budgets.
